Immunogenicity and safety of co-purified diphtheria, tetanus and acellular pertussis vaccine in 6-year-old Chinese children. [PDF]
Nat CommunTang X +16 more
europepmc +1 more source
WG interpretations : cost effectiveness of Tdap in adults aged 65 years and older [PDF]
06-pertussis-Liang ...
core
Efficacy, Immunogenicity, and Safety of Pertussis Vaccine During Pregnancy: A Meta-Analysis. [PDF]
Vaccines (Basel)Shi Q +8 more
europepmc +1 more source
Maternal Pertussis Immunization and Immunoglobulin G Levels in Early- to Late-Term and Preterm Infants [PDF]
Importance: Maternal tetanus, diphtheria, and acellular pertussis (Tdap) vaccination protects newborns against severe pertussis. Data on transplacental antibody transfer on Tdap vaccination before 24 weeks' gestation remain scarce and are particularly ...
Dutch Maternal Pertussis Vaccine Investigation Group
core
Safety Evaluation of Tetanus, Diphtheria, and Acellular Pertussis Vaccine (Tdap) During Pregnancy Among Vietnamese Women. [PDF]
Vaccines (Basel)Nguyen HM, Tran NT, Pham QH, Cao HN.
europepmc +1 more source
Pertussis Vaccine in COPD and Asthma: An Old Acquaintance Is Back. [PDF]
Open Respir Arch, 2022 Villar-Álvarez F +2 more
europepmc +1 more source
Systemic priming and intranasal booster with a BcfA-adjuvanted acellular pertussis vaccine generates CD4+ IL-17+ nasal tissue resident T cells and reduces B. pertussis nasal colonization. [PDF]
Front Immunol, 2023 Yount KS +11 more
europepmc +1 more source
Diphtheria-tetanus-acellular pertussis vaccine safety in children under 7 years: a post-marketing analysis of the U.S. vaccine adverse event reporting system. [PDF]
Front Cell Infect MicrobiolLiu M +6 more
europepmc +1 more source